Showing results (2561-2570 of 2,915) with videos related to

Sort By:
Pageof 292
The Journal of Molecular Diagnostics : JMD|July 29, 2021
Hearing Impairment with Monoallelic GJB2 Variants: A GJB2 Cause or Non-GJB2 Cause?Yi-Hsin Lin, Ping-Che Wu, Cheng-Yu Tsai, et al.
Cell Cycle (Georgetown, Tex.)|March 21, 2022
Compound cellular stress maximizes apoptosis independently of p53 in glioblastomaCheng-Jung Ho, Cheng-Yu Tsai, Wei-Hua Zhu, et al.
The Plant Journal : for Cell and Molecular Biology|January 25, 2012
Footprints of natural and artificial selection for photoperiod pathway genes in OryzaChao-Li Huang, Cheng-Yu Hung, Yu-Chung Chiang, et al.
Anticancer Research|November 1, 2016
MicroRNA-324 in Human Cancer: miR-324-5p and miR-324-3p Have Distinct Biological Functions in Human CancerWei-Ting Kuo, Shou-Yu Yu, Sung-Chou Li, et al.
Fish & Shellfish Immunology|September 15, 2024
A molecular mechanism underlies grass carp (Ctenopharyngodon idella) TARBP2 regulating PKR-mediated cell apoptosisMiao-Miao Li, Chang-Bai Tao, Mei-Feng Li, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 3, 2021
Protein energy wasting-based nutritional assessment predicts outcomes of acute ischemic stroke and solves the epidemiologic paradoxLi-Chun Ho, Hao-Kuang Wang, Lu-Ting Chiu, et al.
Postgraduate Medicine|August 5, 2021
Renal dysfunction is associated with lower odds of home discharge for patients with strokeI-Kuan Wang, Tung-Min Yu, Tzung-Hai Yen, et al.
Transboundary and Emerging Diseases|September 24, 2022
Mutation of D201G near the receptor binding site significantly drives antigenic drift of circulating H9N2 subtype avian influenza virusJing Xia, Yu-Wen Luo, Meng-Yi Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2018
Machine Learning-Based Radiomics for Molecular Subtyping of GliomasChia-Feng Lu, Fei-Ting Hsu, Kevin Li-Chun Hsieh, et al.
International Journal of Cancer|December 31, 2025
Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China studyYi-Long Wu, Li Zhang, Yun Fan, et al.
Pageof 292